Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇦CA · Life Sciences#8530K to 100K
- 🇯🇵JP · Life Sciences#9310K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
20K to 65K🎙 ~2x weekly·120 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
40K to 130K🇨🇦77%🇯🇵23% - Active Followers
Loyal subscribers who consistently listen
12K to 39K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
S16 E04 Bringing Innovative Therapies to Canada
Jun 24, 2026
28m 57s
S16 E03 Learning to Do More With Less: Leandra Wells on How to Rethink Pharma Strategy
Jun 17, 2026
26m 35s
S16 E02 Healthcare Investing and Life Sciences Innovation in 2026: Bloom’s View
Jun 3, 2026
32m 03s
S16 E01 Overcoming Misconceptions about the Canadian Pharma Market
May 27, 2026
32m 15s
S15 E08 The Inevitability of AI in Healthcare
Apr 22, 2026
42m 26s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/24/26 |  S16 E04 Bringing Innovative Therapies to Canada | Associate Vice-President and GM of Incyte’s Chris White discusses Most Favoured Nation pricing impacts, drug access and reimbursement, and wildly authentic leadership. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 28m 57s | ||||||
| 6/17/26 |  S16 E03 Learning to Do More With Less: Leandra Wells on How to Rethink Pharma Strategy | Founder of Brighthive Innovation Group’s Leandra Wells discusses tech enablement, transforming organization on lean budgets, and prioritizing healthcare in Canada. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 26m 35s | ||||||
| 6/3/26 |  S16 E02 Healthcare Investing and Life Sciences Innovation in 2026: Bloom’s View | CEO of Bloom Burton’s Brian Bloom discusses the themes of the 2025 Bloom Burton conference, return entrepreneurs in the Canadian Life Sciences landscape, and accelerating drug discovery with AI. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 32m 03s | ||||||
| 5/27/26 |  S16 E01 Overcoming Misconceptions about the Canadian Pharma Market | Canadian General Manager of argenx’s John Haslam discusses the big impact of rare disease, making key antibodies in the autoimmune space, and pricing strategy reform in Canada. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 32m 15s | ||||||
| 4/22/26 |  S15 E08 The Inevitability of AI in Healthcare | CEO of Toboggan Labs’ Florencia Herra Vega discusses AI compliance and innovation, applying AI to the whole team instead of individually, and useful technology for quick solutions. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 42m 26s | ||||||
| 3/25/26 |  S15 E07 The Importance of Commercial Product Pre-Launch | Country Manager of Merz Therapeutics’ Mike Stone discusses commercial launches, the speed of mid-sized pharma, and rebranding DEI. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 31m 49s | ||||||
| 3/18/26 |  S15 E06 Healthcare Policy and the Medical Community | Leverage’s Ian Howard discusses his time working in the public sector, treating illness versus promoting wellness, and the rise of cosmetic dermatology. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 35m 21s | ||||||
| 3/4/26 |  S15 E05 Assisting Better Health Outcomes in Pharma | National Director of Account Management of Sales of IQVIA’s Chris Hankey discusses biobanking, digital transformation, and better health outcomes for patients. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 27m 53s | ||||||
| 2/25/26 |  S15 E04 Building Resilience into Patient Support Programs | Director of Business Development of Bayshore Specialty Rx’s Shaminder Singh discusses patient support and care delivery, building adaptability and resilience into patient support programs, and the future of healthcare funding in Canada Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 24m 59s | ||||||
| 2/18/26 |  S15 E03 Maintaining Commercial Excellence at EMD Serono | Head of Canadian Commercial Operations and Strategic Advisor of EMD Serono’s Khalid Sabihuddin discusses translating complex analytics into actionable guidance, international healthcare perspectives, and the healthcare policy climate. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 30m 07s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/28/26 |  S15 E02 Mike Cloutier’s Leadership Journey | Co-Chairman of BridgeBright Advisors’ Mike Cloutier discusses leadership at scale, leadership in the current political climate, and the hardware for being a successful leader. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 42m 39s | ||||||
| 1/21/26 |  S15 E01 What Keeps Pharma Companies Up At Night | Pangaea Consultants’ Managing Director Jeff Martens discusses going from an operating role to consulting, lack of access in today’s political climate, and doing less with more. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 31m 16s | ||||||
| 10/22/25 |  S14 E08 Seaford Pharmaceuticals’ Journey as a Family-owned Canadian Company | Seaford President Tamara Seales discusses navigating Canadian pharma regulations, team-building, and weaving DEI into the fabric of the company. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 33m 20s | ||||||
| 10/8/25 |  S14 E07 Workplace Cultures Around the World in Big and Small Pharma | Mike Exton, CEO and Board Director of Lexicon Pharmaceuticals, talks about safeguards and limits for AI, smaller pharma veresus big pharma, and brand strategies based on data over belief. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 41m 47s | ||||||
| 8/13/25 |  S14 E06 The Economics and Ethics of Life Sciences - With Gordon McCauley | Gordon McCauley, CEO of adMare BioInnovations, unpacks the profits, principles, and policies shaping today’s life sci industry. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 30m 35s | ||||||
| 8/6/25 |  S14 E05 Prioritizing Humility, Integrity and Curiosity in Leadership | Casey James Lawton, General Manager at Peirre Fabre Dermo-Cosmetic, talks about diverse career experiences, learning to pivot, and building strong, science-driven foundations. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 29m 02s | ||||||
| 7/30/25 |  S14 E04 Bringing Oncology Care to Canada with Daiichi Sankyo | Fatih Yetikardes, Country Manager of Daiichi Sankyo, gives insights into advancing patient care with company collaborations, the unique complexities of the Canadian healthcare system, and the ethical use and transparent governance of AI. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 31m 19s | ||||||
| 7/17/25 |  S14 E03 Sobi Canada’s Bob McLay: Life Science Leadership in Rare Disease | Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 31m 33s | ||||||
| 7/10/25 |  S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics | Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 25m 00s | ||||||
| 4/23/25 |  S14 E01 Dr. Bettina Hamelin and The Role of Innovative Medicines Canada | Dr. Bettina Hamelin, President of Innovative Medicines Canada, gives insights into the adoption of innovative technologies, domestic supply chain for pharmaceuticals, and excluding medicines as retaliatory measures for tariffs. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 30m 26s | ||||||
| 3/19/25 |  S13 E08 Tariffs and the Effect on Canadian Pharma Companies | Paul Levesque, President and CEO of Theratechnologies Inc., gives insights into innovation in biopharma, the effects of tariffs on supply chain and pharma manufacturing, and cross-border business development. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 30m 17s | ||||||
| 3/12/25 |  S13 E07 Serving Women’s Health in the Specialty Pharma Sector | Mark Nawacki, President and CEO of Searchlight Pharma, gives insights into starting a specialty pharma business, therapeutics for women’s health and migraine relief, and the shift to more personalized medicines in healthcare. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 29m 29s | ||||||
| 3/5/25 |  S13 E06 Innovation and Market Access in Pharma | Lisa Mullett, Senior Vice-President of Sumitomo Pharma America, gives insights into the importance of diversity in companies and patient trials, stepping out of your comfort zone to further your career, and accelerating development with AI. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 27m 04s | ||||||
| 12/11/24 |  S13 E05 AI and the Importance of Data to Pharma Marketers | Tom Slowe, CEO of Breadcrumb Analytics, gives insights into using AI to sort and sift through statistics, the importance of context with data, and why AI should only be supplementary to human work. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 29m 32s | ||||||
| 11/20/24 |  S13 E04 Eli Lilly’s Focus on Innovative Therapeutics | Kenneth Custer, President and General Manager of Eli Lilly Canada, gives insights into his background in neuroscience, innovation in healthcare, and progress in therapeutics for obesity and Alzheimer’s. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe | 23m 39s | ||||||
Showing 25 of 125
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.